The clinical pharmacology of fluconazole.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Reporting results of cancer treatment
1981 • 7,916 citations
MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma
1985 • 677 citations
Diffuse Aggressive Lymphomas: Increased Survival After Alternating Flexible Sequences of ProMACE and MOPP Chemotherapy
1983 • 384 citations
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
1983 • 343 citations
Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor.
1985 • 314 citations
Mitoxantrone: A New Anticancer Drug with Significant Clinical Activity
1986 • 288 citations
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy
1982 • 272 citations
High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia
1987 • 201 citations
Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug COP-BLAM Regimen
1982 • 189 citations
Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)
1982 • 130 citations
High-dose cytosine arabinoside in non-Hodgkin's lymphoma.
1983 • 76 citations
High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphoma
1985 • 38 citations
High-dose cytosine arabinoside
1984 • 34 citations
Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma
1989 • 33 citations
Mitoxantrone in malignant lymphomas
1983 • 24 citations
Mitoxantrone hydrochloride in lymphoma
1983 • 19 citations